These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 31551786)
1. Metabolic Profiling Analysis of Patients With Coronary Heart Disease Undergoing Xuefu Zhuyu Decoction Treatment. Tao T; He T; Wang X; Liu X Front Pharmacol; 2019; 10():985. PubMed ID: 31551786 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach. Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624 [TBL] [Abstract][Full Text] [Related]
3. Non-Targeted Metabolomic Profiling of Coronary Heart Disease Patients With Taohong Siwu Decoction Treatment. Tao T; He T; Mao H; Wu X; Liu X Front Pharmacol; 2020; 11():651. PubMed ID: 32457630 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy and mechanism of Xuefu Zhuyu Decoction on model rats of coronary heart disease with heart blood stasis syndrome based on metabolomics]. Li J; Guo ZH; Liu JH; Zhong SJ; Kuang HF; Yang Y; Liu Y; Zhang QY Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5623-5631. PubMed ID: 38114155 [TBL] [Abstract][Full Text] [Related]
5. Yi M; Dai X; Li Q; Zhao Y; Nie S; Wang D Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):591-600. PubMed ID: 34275927 [TBL] [Abstract][Full Text] [Related]
6. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats. Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757 [TBL] [Abstract][Full Text] [Related]
7. Metabolomics reveals the effect of Xuefu Zhuyu Decoction on plasma metabolism in rats with acute traumatic brain injury. Feng D; Xia Z; Zhou J; Lu H; Zhang C; Fan R; Xiong X; Cui H; Gan P; Huang W; Peng W; He F; Wang Z; Wang Y; Tang T Oncotarget; 2017 Nov; 8(55):94692-94710. PubMed ID: 29212259 [TBL] [Abstract][Full Text] [Related]
8. A Chinese classical prescription Xuefu Zhuyu decoction in the treatment of coronary heart disease: An overview. Wang X; Xing X; Huang P; Zhang Z; Zhou Z; Liang L; Yao R; Wu X; Yang L Heliyon; 2024 Apr; 10(7):e28919. PubMed ID: 38617912 [TBL] [Abstract][Full Text] [Related]
9. Effects of Xuefu Zhuyu Granules on Patients with Stable Coronary Heart Disease: A Double-Blind, Randomized, and Placebo-Controlled Study. Li Y; Tao T; Song D; He T; Liu X Oxid Med Cell Longev; 2021; 2021():8877296. PubMed ID: 34326921 [TBL] [Abstract][Full Text] [Related]
10. Study of Serum Metabonomics and Formula-Pattern Correspondence in Coronary Heart Disease Patients Diagnosed as Phlegm or Blood Stasis Pattern Based on Ultra Performance Liquid Chromatography Mass Spectrometry. Lu XY; Xu H; Zhao T; Li G Chin J Integr Med; 2018 Dec; 24(12):905-911. PubMed ID: 29948595 [TBL] [Abstract][Full Text] [Related]
11. Qi-Regulating and Blood Circulation-Promoting Therapy Improves Health Status of Stable Angina Pectoris Patients with Depressive Symptoms. Wang XR; Song DD; Tao TQ; He T; Wu XD; Li XM; Liu XH Evid Based Complement Alternat Med; 2021; 2021():7319417. PubMed ID: 34567219 [TBL] [Abstract][Full Text] [Related]
12. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy. Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490 [No Abstract] [Full Text] [Related]
13. Urinary metabolomic profiling reveals difference between two traditional Chinese medicine subtypes of coronary heart disease. Guo N; Chen Y; Yang X; Yan H; Fan B; Quan J; Wang M; Yang H J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122808. PubMed ID: 34218095 [TBL] [Abstract][Full Text] [Related]
14. UPLC-ESI-IT-TOF-MS metabolomic study of the therapeutic effect of Xuefu Zhuyu decoction on rats with traumatic brain injury. Fu C; Wu Q; Zhang Z; Xia Z; Ji H; Lu H; Wang Y J Ethnopharmacol; 2019 Dec; 245():112149. PubMed ID: 31401321 [TBL] [Abstract][Full Text] [Related]
15. Research on Effect and Mechanism of Xuefu Zhuyu Decoction on CHD Based on Meta-Analysis and Network Pharmacology. Kui F; Gu W; Gao F; Niu Y; Li W; Zhang Y; Guo L; Wang J; Guo Z; Cen S; Du G Evid Based Complement Alternat Med; 2021; 2021():9473531. PubMed ID: 33628326 [TBL] [Abstract][Full Text] [Related]
16. [Coronary heart disease: innovative understanding from traditional Chinese medicine and treatment by classic formulas]. Lan Y; Luo FK; Yu Y; Wang XY; Wang PQ; Xiong XJ Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3684-3692. PubMed ID: 39041141 [TBL] [Abstract][Full Text] [Related]
17. Xuefu Zhuyu decoction, a traditional Chinese medicine, provides neuroprotection in a rat model of traumatic brain injury via an anti-inflammatory pathway. Xing Z; Xia Z; Peng W; Li J; Zhang C; Fu C; Tang T; Luo J; Zou Y; Fan R; Liu W; Xiong X; Huang W; Sheng C; Gan P; Wang Y Sci Rep; 2016 Jan; 6():20040. PubMed ID: 26818584 [TBL] [Abstract][Full Text] [Related]
18. Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis. Yi M; Li Q; Zhao Y; Nie S; Wu N; Wang D Drug Metab Pharmacokinet; 2019 Oct; 34(5):340-349. PubMed ID: 31474470 [TBL] [Abstract][Full Text] [Related]
19. [A randomized double-blinded controlled trial of Xuefu Zhuyu Capsule on short-term quality of life in unstable anginal patients with blood-stasis syndrome after percutaneous coronary intervention]. Chu FY; Wang J; Sun XW; Xing YW; Yao KW; Wang SH; Li ZZ Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):729-35. PubMed ID: 19671410 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Xuefu Zhuyu Granules combined with western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial. Liu D; Zeng Y; Liang P; Jiang Y; An S; Ren P Medicine (Baltimore); 2022 Oct; 101(43):e31235. PubMed ID: 36316861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]